Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-06-30 View official record Methodology

Covered recipient · General Payments record

KELLE D MONROE

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family

NPI
1366199580
CMS profile
11348480
Location
PITTSFIELD, IL

General Payments · PY2022–2025

$980.61

  • Reported across 54 records
  • CMS publication 2026-06-30

Latest program year · PY2025

$266.00

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2025 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $266.00 15

By paying entity

PY2025 · sorted by reported total

Paying entityAmountRecords
Novo Nordisk AS $111.52 6
Lilly USA, LLC $69.23 4
Amgen Inc. $31.37 2
Bayer HealthCare Pharmaceuticals Inc. $20.68 1
Axsome Therapeutics, Inc. $18.47 1
Phathom Pharmaceuticals, Inc. $14.73 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2022 $120.92 6
PY2023 $257.39 15
PY2024 $336.30 18
PY2025 $266.00 15

Payment records · PY2025 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2025 202220232024 Record-level detail is published for PY2025; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $16.19 03/19/2025 Food and Beverage Undisputed 06/30/2026 1229087590 CMS
Amgen Inc. $15.18 08/29/2025 Food and Beverage Undisputed 06/30/2026 1229087582 CMS
Axsome Therapeutics, Inc. $18.47 10/16/2025 Food and Beverage Undisputed 06/30/2026 1235547346 CMS
Bayer Healthcare Pharmaceuticals Inc. $20.68 02/03/2025 Food and Beverage Undisputed 06/30/2026 1225659017 CMS
Lilly USA, LLC $18.83 03/03/2025 Food and Beverage Undisputed 06/30/2026 1187165923 CMS
Lilly USA, LLC $20.00 07/08/2025 Food and Beverage Undisputed 06/30/2026 1187199893 CMS
Lilly USA, LLC $16.40 09/16/2025 Food and Beverage Undisputed 06/30/2026 1187150126 CMS
Lilly USA, LLC $14.00 09/22/2025 Food and Beverage Undisputed 06/30/2026 1187138619 CMS
Novo Nordisk Inc $13.82 01/14/2025 Food and Beverage Undisputed 06/30/2026 1189067262 CMS
Novo Nordisk Inc $15.89 03/11/2025 Food and Beverage Undisputed 06/30/2026 1189104055 CMS
Novo Nordisk Inc $23.60 05/13/2025 Food and Beverage Undisputed 06/30/2026 1188855340 CMS
Novo Nordisk Inc $16.94 10/20/2025 Food and Beverage Undisputed 06/30/2026 1188516651 CMS
Novo Nordisk Inc $20.11 11/12/2025 Food and Beverage Undisputed 06/30/2026 1188621106 CMS
Novo Nordisk Inc $21.16 12/02/2025 Food and Beverage Undisputed 06/30/2026 1188919222 CMS
Phathom Pharmaceuticals, Inc. $14.73 02/04/2025 Food and Beverage Undisputed 06/30/2026 1219332874 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2022, 2023, 2024, 2025
Source files
Dataset page · Bulk file · PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.